We are monitoring the impact of COVID-19 on Latin America Cancer Immunotherapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1340
Share on
Share on

Latin America Cancer Immunotherapy Market Research Report – Segmented By Application, Product Type, Mode Of Administration, End Users, Country (Mexico, Brazil, Argentina, Chile and Rest of Latin America) - Industry Analysis, Size, Share, Growth, Trends, Forecast | 2020 to 2025

Pulished: February, 2020
ID: 1340
Pages: 132

The Latin America Cancer Immunotherapy Market size is estimated to grow from USD 11.8 Billion in 2019 to USD 20.89 Billion by the end of 2024, with a growing potential of 12.10%.

Immunotherapy is a type of treatment option that helps your immune system fight against cancer. According to the World Health Organization report in 2018, there are 9.6 million people suffered from cancer. Also, 1 out of 6 deaths is due to cancer globally. Usually, the immune system helps the body fight against infections and other diseases.  Cancer immunotherapy helps in preventing the growth of the cancer cells, inhibiting the cancer cells from spreading across the body. It helps the immune system to fight better against the cancer cells.

The key drivers influencing the growth of Latin America Cancer immunotherapy market are increasing occurrence of cancer, Changing lifestyle, Smoking and excessive alcohol intake, high efficacy of immunotherapy compared to other treatments, fewer side effects associated with cancer immunotherapy, reduced chance of recurrence of cancer.

Various cancers like Melanoma shows resistance towards chemotherapy and radiation therapies, Cost of cancer therapies, limited information on cancer immunobiology are the significant factors limiting the growth of the market.

This research report has been segmented & sub-segmented into the following categories:

  • By Type of Therapies: Immune System Modulators, Immune Checkpoint Inhibitors & Monoclonal Antibodies
  • By Area of Therapy: Blood Cancer, Prostate Cancer, Melanoma, Breast Cancer, Lung Cancer, Colorectal Cancer & Other Minor Areas
  • By Country: Mexico, Brazil, Argentina, Chile and Rest of Latin America

Regional Analysis

Brazilian cancer immunotherapy market is witnessed in holding the highest shares of the Latin American market from the past few years and is to continue the same growth rate in the forecast period. Increasing incidences of chronic diseases such as cancer is a significant factor for the market to grow. On-going research and development activities are escalating the demand of the market. Brazil has its healthcare system for the cancer treatment in 2017, i.e. Brazil's National health system. They developed cancer Care policies in favour of ordinary people.

Mexican cancer immunotherapy market is positioned second in leading dominant shares of the market. Growing support from government organizations and rise in the number of people who have cancer are likely to propel the demand of the market. 

Notable companies in the LATAM cancer immunotherapy Market are F. Hoffmann-La Roche Ltd, Amgen, Viralytics, Novartis Pharmaceuticals Corporation, Pfizer, GlaxoSmithKline Pharmaceuticals Limited, AstraZeneca plc, Medivation, Advaxis, Bristol-Myers Squibb, Merck & Co. and Celgene Corp and Immunomedics.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Breast       

                                5.1.3 Lung          

                                5.1.4 Melanoma              

                                5.1.5 Colorectal

                                5.1.6 Head & Neck          

                                5.1.7 Prostate   

                                5.1.8 Others      

                                5.1.9 Y-o-Y Growth Analysis, By Application         

                                5.1.10 Market Attractiveness Analysis, By Application     

                                5.1.11 Market Share Analysis, By Application      

                5.2 Product Type                             

                                5.2.1 Introduction           

                                5.2.2 Monoclonal Antibodies     

                                5.2.3 Checkpoint inhibitors/immune modulators              

                                5.2.4 Therapeutic cancer vaccines            

                                5.2.5 Oncolytic virus immunotherapy     

                                5.2.6 Cytokines

                                5.2.7 Adoptive T cell transfer     

                                5.2.8 Adjuvant Immunotherapy

                                5.2.9 Interferons             

                                5.2.10 Interleukins         

                                5.2.11 BCG         

                                5.2.12 Others   

                                5.2.13 Y-o-Y Growth Analysis, By Product Type   

                                5.2.14 Market Attractiveness Analysis, By Product Type

                                5.2.15 Market Share Analysis, By Product Type  

                5.3 Mode of Administration                        

                                5.3.1 Introduction           

                                5.3.2 Intravenous           

                                5.3.3 Oral            

                                5.3.4 Topical      

                                5.3.5 Intra Vesical           

                                5.3.6 Y-o-Y Growth Analysis, By Mode of Administration

                                5.3.7 Market Attractiveness Analysis, By Mode of Administration              

                                5.3.8 Market Share Analysis, By Mode of Administration

                5.3 End users                    

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Clinics        

                                5.3.4 Y-o-Y Growth Analysis, By End users            

                                5.3.5 Market Attractiveness Analysis, By End users           

                                5.3.6 Market Share Analysis, By End users            

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Product Type

                                                6.1.3.4 By Mode of Administration

                                                6.1.3.5 By End users

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Product Type

                                                6.1.4.4 By Mode of Administration

                                                6.1.4.5 By End users

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Product Type

                                                6.1.5.4 By Mode of Administration

                                                6.1.5.6 By End users

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 F. Hoffmann-La Roche Ltd                    

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Amgen                         

                8.3 Viralytics                      

                8.4 Novartis Pharmaceuticals Corporation                            

                8.5 Pfizer                            

                8.6 GlaxoSmithKline Pharmaceuticals Limited                     

                8.7 AstraZeneca plc                        

                8.8 Medivation                

                8.9 Advaxis                        

                8.10 Bristol-Myers Squibb                           

                8.11 Merck & Co. and Celgene Corp                        

                8.12 Immunomedics                      

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Latin America Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  2. Latin America Breast Market By Region, From 2020 to 2025 (USD Billion)
  3. Latin America Lung Market By Region, From 2020 to 2025 (USD Billion)
  4. Latin America Melanoma Market By Region, From 2020 to 2025 (USD Billion)
  5. Latin America Colorectal Market By Region, From 2020 to 2025 (USD Billion)
  6. Latin America Head & Neck Market By Region, From 2020 to 2025 (USD Billion)
  7. Latin America Prostate Market By Region, From 2020 to 2025 (USD Billion)
  8. Latin America Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  9. Latin America Monoclonal Antibodies Market By Region, From 2020 to 2025 (USD Billion)
  10. Latin America Checkpoint inhibitors/immune modulators Market By Region, From 2020 to 2025 (USD Billion)
  11. Latin America Therapeutic cancer vaccines Market By Region, From 2020 to 2025 (USD Billion)
  12. Latin America Oncolytic virus immunotherapy Market By Region, From 2020 to 2025 (USD Billion)
  13. Latin America Cytokines Market By Region, From 2020 to 2025 (USD Billion)
  14. Latin America Adoptive T cell Transfer Market By Region, From 2020 to 2025 (USD Billion)
  15. Latin America Adjuvant immunotherapy Market By Region, From 2020 to 2025 (USD Billion)
  16. Latin America Interferons Market By Region, From 2020 to 2025 (USD Billion)
  17. Latin America Interleukins Market By Region, From 2020 to 2025 (USD Billion)
  18. Latin America BCG Market By Region, From 2020 to 2025 (USD Billion)
  19. Latin America Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  20. Latin America Intravenous Market By Region, From 2020 to 2025 (USD Billion)
  21. Latin America Oral Market By Region, From 2020 to 2025 (USD Billion)
  22. Latin America Topical Market By Region, From 2020 to 2025 (USD Billion)
  23. Latin America Intravesical Market By Region, From 2020 to 2025 (USD Billion)
  24. Latin America Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)
  25. Latin America hospitals Market By Region, From 2020 to 2025 (USD Billion)
  26. Latin America Clinics Market By Region, From 2020 to 2025 (USD Billion)
  27. Brazil Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  28. Brazil Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  29. Brazil Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  30. Brazil Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)
  31. Argentina Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  32. Argentina Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  33. Argentina Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  34. Argentina Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)
  35. Mexico Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  36. Mexico Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  37. Mexico Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  38. Mexico Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)
  39. Rest of Latin America Cancer Immunotherapy Market By Application, From 2020 to 2025 (USD Billion)
  40. Rest of Latin America Cancer Immunotherapy Market By Product Type, From 2020 to 2025 (USD Billion)
  41. Rest of Latin America Cancer Immunotherapy Market By Mode of Administration, From 2020 to 2025 (USD Billion)
  42. Rest of Latin America Cancer Immunotherapy Market By End users, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample